Cutaneous arteritis combined with antiphospholipid syndrome associated with the use of immune checkpoint inhibitors in a patient with a metastatic lung adenocarcinoma

J Dermatol. 2024 May;51(5):e166-e167. doi: 10.1111/1346-8138.17063. Epub 2023 Dec 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma of Lung* / drug therapy
  • Adenocarcinoma of Lung* / immunology
  • Adenocarcinoma of Lung* / secondary
  • Aged
  • Antiphospholipid Syndrome* / complications
  • Antiphospholipid Syndrome* / diagnosis
  • Antiphospholipid Syndrome* / drug therapy
  • Antiphospholipid Syndrome* / immunology
  • Arteritis* / chemically induced
  • Arteritis* / diagnosis
  • Arteritis* / drug therapy
  • Arteritis* / etiology
  • Arteritis* / immunology
  • Female
  • Humans
  • Immune Checkpoint Inhibitors* / adverse effects
  • Immune Checkpoint Inhibitors* / therapeutic use
  • Lung Neoplasms* / complications
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / secondary
  • Male
  • Middle Aged
  • Skin / immunology
  • Skin / pathology

Substances

  • Immune Checkpoint Inhibitors